Page 4 - Flipbook for Biotech Showcase 2019

Sheppard Mullin has offices serving the full range of the life sciences sector in Palo Alto, San Diego/Del Mar, Los Angeles, San Francisco, Orange County, New York, Washington DC, Beijing, Shanghai, and Brussels. Attorneys in these offices work with life sciences companies in every phase of their growth cycle. Our team includes attorneys with advanced or technical degrees, as well as former in-house counsel of life sciences companies. The depth and breadth of their experience enables us to better understand our clients’ business and objectives.
Our life sciences team assists promising startups, publicly held multinational corporations, research institutions, government agencies and investors, to protect and leverage intellectual property; raise and deploy capital; structure mergers, acquisitions, dispositions, strategic alliances, joint ventures, and spin-offs; navigate legislative and regulatory issues; and develop, lease, and acquire R&D and laboratory facilities. We also work with our life sciences clients as they access the capital markets through initial public offerings or private placements and consult with them on corporate governance and SEC compliance issues. In an industry where partnerships and collaborations are on the rise and there is pressure to produce results, we work hand-in-hand with our clients in their drive for success and profitability.
Sheppard Mullin’s life sciences industry team represents pharmaceutical, biotechnology, medical diagnostic, and medical device companies, as well as their investors in one or more of these areas:
CORPORATE
• Formation and Organization
• Venture Capital
• Joint Ventures and Strategic Alliances • Manufacturing, Supply, and
Distribution Agreements
• Mergers & Acquisitions
• Employee Benefits and Executive Compensation • Securities Law
FINANCE AND CAPITAL MARKETS
• Corporate Finance representing issuers, private equity funds, and venture capital firms
• Structuring debt and equity investments, including secured investments
• Monetizing royalties from intellectual property licenses
INTELLECTUAL PROPERTY
• Patent Prosecution and Counseling, including complex global patent portfolio design and management
• Licensing
• Prosecution
REGULATORY
• FDA
• Clinical Trials • Healthcare
• Environmental
LABOR AND EMPLOYMENT
• Litigation
• Transactional • Counseling
• Immigration
LITIGATION
• Complex Commercial — trial and appellate including trademark, trade secret, antitrust, and unfair competition matters
• Patents and Intellectual Property • Products Liability
ANTITRUST AND COMPETITION
• Cartels
• Abuse of Dominance
• Merger Control
• Licensing
• Originator/Generic Competition • Lifecycle Management
• Pricing/Reimbursement Issues • EU Pharmaceutical Regulation • Private Litigation
BANKRUPTCY AND CREDITORS’ RIGHTS
REAL ESTATE
• Acquisition and Leasing
• Land Use and Regulation
• Infrastructure and Facilities Financing
TAX